Long-term eculizumab improves clinical outcomes in atypical hemolytic uremic syndrome

BACKGROUND: Atypical hemolytic uremic syndrome (aHUS) is a rare genetic disorder caused by chronic uncontrolled complement activation. CASE-DIAGNOSIS/TREATMENT: We present a 4-year-old girl with aHUS who had multiple severe clinical manifestations of thrombotic microangiopathy (TMA) including acute...

Descripción completa

Detalles Bibliográficos
Autores principales: Vilalta, Ramon, Lara, Enrique, Madrid, Alvaro, Chocron, Sara, Muñoz, Marina, Casquero, Alex, Nieto, Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491201/
https://www.ncbi.nlm.nih.gov/pubmed/22890512
http://dx.doi.org/10.1007/s00467-012-2276-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3491201/
https://www.ncbi.nlm.nih.gov/pubmed/22890512
http://dx.doi.org/10.1007/s00467-012-2276-8

Ejemplares similares